Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
44.99%Depreciation and Amortization Margin
VS
Market
Sector
Industry
History
$ 0.4Close
$ 0.27 - $ 0.47 52-Week Range
Ticker Information
Ticker
IGCCompany Name
IGC PHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NYSEMKTIGC PHARMA INC - Depreciation and Amortization Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
IGC - DepAmor % Historical data
| Date | Depreciation, Amortization & Accretion | Depreciation and Amortization Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 597K | 44.99% | $ 1.33M |
| 3/31/2025 | $ 618K | 48.62% | $ 1.27M |
| 12/31/2024 | $ 628K | 50.81% | $ 1.24M |
| 9/30/2024 | $ 631K | 53.34% | $ 1.18M |
| 6/30/2024 | $ 644K | 60.64% | $ 1.06M |
| 3/31/2024 | $ 637K | 47.36% | $ 1.34M |
| 12/31/2023 | $ 626K | 51.48% | $ 1.22M |
| 9/30/2023 | $ 638K | 47.47% | $ 1.34M |
| 6/30/2023 | $ 650K | 51.79% | $ 1.25M |
| 3/31/2023 | $ 657K | 72.12% | $ 911K |
Key Performance Insights, Last 5 Years
- IGC PHARMA INC's latest trailing twelve months (TTM) DepAmor % stands at 21.66%.
- Over the past 5 years, IGC PHARMA INC's average DepAmor % has been 81.38%.
- The median DepAmor % for IGC PHARMA INC during this period was 53.28%
- IGC PHARMA INC reached its highest DepAmor % over the past 5 years at 190.37%.
- The lowest DepAmor % recorded by IGC PHARMA INC in the same timeframe 21.66%
IGC PHARMA INC's DepAmor % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
DepAmor % Benchmarks
Similar metrics to Revenues:
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation, Amortization & Accretion - [Cash Flow Statement] A component of operating cash flow [NCFO] representing the aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a non-cash item, the net amount is added back to net income when calculating cash provided by operations.
Definition of Depreciation and Amortization Margin
[Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].DepAmor / Revenues
(=) DepAmor % DepAmor % for IGC PHARMA INC is calculated as follows: DepAmor [ $ 284K ] / Revenues [ $ 1.31M ]
(=) DepAmor % [ 21.66% ] IGC - Depreciation and Amortization Margin, Last 5 years
21.66%
Minimum
Sep 30, 2020
190.37%
Maximum
Sep 30, 2021
81.38%
Average
53.28%
Median
DepAmor % Benchmark AnalysisMarket
The chart above depicts the distribution of DepAmor % for companies in the Total Stock Market. The average DepAmor % of the companies is 5.85% with a standard deviation of 5.12%.
The following table provides additional summary stats:
DepAmor % in the Market:
| filtered constituents | 3.31K |
|---|---|
| min | -6.41% |
| max | 22.52% |
| average | 5.85% |
| median | 4.22% |
| std | 5.12% |